or Try an Advanced Search...

    ETF Components for FBT - First Trust Amex Biotech Index Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    EXEL B 0.23 4.51
    CORT B 0.53 4.07
    INCY C 0.07 3.97
    NTRA A 1.54 3.92
    ITCI B -0.07 3.90
    ACAD C -0.25 3.85
    ARGX A -0.58 3.74
    GILD B 1.10 3.66
    UTHR C 0.97 3.64
    CPRX C -0.43 3.62
    NBIX C 2.01 3.59
    WAT B 1.90 3.55
    RGEN D 0.63 3.46
    HALO F -0.96 3.44
    VRTX D -0.43 3.39
    ALKS C -0.41 3.31
    ILMN C 1.62 3.30
    BMRN F 0.30 3.15
    ALNY D 0.51 3.06
    GMAB F 0.54 3.04
    AMGN D 0.05 3.04
    SRPT F -0.70 2.96
    BIIB F 0.82 2.95
    BNTX D 2.88 2.90
    MTD F 0.57 2.88
    BRKR F 3.11 2.85
    BGNE D 0.74 2.76
    REGN F 0.64 2.60
    EXAS D 1.98 2.42
    MRNA F 0.38 2.30

    Represented by ETF Holdings

    Keywords: Biotechnology Biopharmaceutical Medicine S&P 500 Nasdaq 100 Cancer Life Sciences Disorders Inflammation Monoclonal Antibodies Monoclonal Antibody Biology Chemical Compounds Clinical Development Clinical Research Diabetes Immunology Infectious Diseases Lymphoma Pain
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities

    Recent News for First Trust Amex Biotech Index Fund & its Holdings

    Date Stock Title
    Nov 21 MRNA Major companies that are also popular short-selling stocks
    Nov 21 AMGN Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
    Nov 21 AMGN Amgen picks prolific biotech founder Chang as new top scientist
    Nov 21 AMGN Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 20 ILMN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
    Nov 20 AMGN AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
    Nov 20 ILMN If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer
    Nov 20 MRNA CDC warns of an imminent spike in COVID, flu cases
    Nov 20 ILMN Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript)
    Nov 20 BRKR Bruker jumps as CEO buys $5M company stock
    Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
    Nov 20 BRKR Bruker Stock Explodes 10.5% After CEO's $5M Insider Bet
    Nov 20 GILD Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)
    Nov 20 AMGN SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
    Nov 20 CORT Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet
    Nov 20 UTHR Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
    Nov 20 ILMN Illumina gear up to expand TruSight Oncology portfolio
    Nov 20 ILMN ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio
    Nov 20 VRTX Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate
    Nov 20 BNTX BioNTech upgraded to Outperform from In Line at Evercore ISI
    The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Stock Market Index Biotechnology
    Back to the Main FBT Page...